Here are four recent news updates on gastroenterology and endoscopy companies.
Analyst Ratings Network.com reported that Boston Scientific has received a consensus rating of "buy" from 24 research firms.
Check-Cap, a capsule endoscopy developer, named William Densel as CEO and director.
Three analyst firms have given EndoChoice stock a $23.33 price target in the short term, according to an OTC Outlook report.
Inc. 500 released its 2015 list, which names the fastest-growing private companies in the country. Modernizing Medicine, the developer of the Electronic Medical Assistant, was named to the list. EMA Gastro is among the company's offerings.
If you have a question, issue or note to suggest on a GI/endoscopy company please contact Carrie Pallardy at email@example.com.